LIVALO® (Pitavastatin). A New Statin approved by the U. S. Food and Drug Administration

August 19, 2009 by Kenneth  
Filed under News and Reviews

In August 03, 2009. The Food and Drug Administration in the U.S. approved LIVALO® (Pitavastatin)for primary hypercholesterolemia and combined Dyslipidemia. Pitavastatin is a fully synthetic statin engineered in Japan by Kowa Pharmaceuticals.
It is a more effective inhibitor of cholesterol production than the statins currently available in the market because of its unique structure. Overall its safety and tolerability are on a par with other normally
prescribed statins.

Sources: Kowa Pharmaceuticals

Related Articles


Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!